Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

Transocean Shares Near $5.30 Amid Focus on Q2 Cash Flow and Noble's Outlook
Markets

Transocean Shares Near $5.30 Amid Focus on Q2 Cash Flow and Noble's Outlook

Transocean shares hover near $5.30 as investors await Q2 earnings, with a focus on cash flow conversion amid strong offshore dayrates.

RIG NE VAL EQNR
Apple Reclaims World's Most Valuable Company Title, Market Rewards Capital Discipline
Analysis

Apple Reclaims World's Most Valuable Company Title, Market Rewards Capital Discipline

Apple surpasses Nvidia in market cap as investors reward its capital-light strategy and strong cash generation, despite Nvidia's faster revenue growth.

AAPL NVDA GOOGL
Nu Holdings Shares Rise 3% in Premarket Despite Buyback Impact
Markets

Nu Holdings Shares Rise 3% in Premarket Despite Buyback Impact

Nu Holdings shares rose 3% in premarket trading, supported by strong Q1 earnings and a new banking license in Brazil, though higher credit-loss allowances and a rising stock price are limiting buyback impact.

NU STNE PAGS
Institutional QQQ Holdings Data Reveals March Positions, Not Fresh Inflows
Markets

Institutional QQQ Holdings Data Reveals March Positions, Not Fresh Inflows

SEC filings reveal QQQ holdings of 440,156 shares worth $254.05 million as of March 31, not new July buys. QQQ trades at $682.12, an 18.2% premium.

QQQ IVZ MSFT AMZN META AAPL
C3is Inc. Shares Recover After Sharp Decline Amid Dilutive Financing
Markets

C3is Inc. Shares Recover After Sharp Decline Amid Dilutive Financing

C3is Inc. shares surged over 100% in premarket trading after an 80.3% decline, but the company's recent financing deal values each potential share at just 10.4 cents.

CISS
AT&T Gains on $10B Buyback, 4.55% Dividend Yield
Markets

AT&T Gains on $10B Buyback, 4.55% Dividend Yield

AT&T shares advanced 0.4% in premarket trading as investors cheered a $10 billion buyback program and a 4.55% dividend yield, with the stock up 10.6% over the past week.

T VZ QBTS
Social Security COLA Seen at 3.8% in 2027, Adding $63B in Benefits
Economy

Social Security COLA Seen at 3.8% in 2027, Adding $63B in Benefits

A 3.8% COLA for 2027 would boost Social Security payouts by $63 billion, but taxes and Medicare costs could cut the net benefit.

SPY
Boring Company Seeks $4 Billion at 200x Sales Valuation
Markets

Boring Company Seeks $4 Billion at 200x Sales Valuation

The Boring Company is raising $4 billion at a proposed $20 billion valuation, a 3.5x increase from 2022, with a sales multiple over 200x.

CRH HII TXT VLTO TSLA MS
Spider-Man Sequel's Record Projection Sparks Theater Stock Rally
Markets

Spider-Man Sequel's Record Projection Sparks Theater Stock Rally

Spider-Man: Brand New Day's projected $195M-$250M U.S.-Canada opening could boost theater stocks. Cinemark reports earnings Thursday; Sony releases the film Friday.

CNK SONY AMC DIS IMAX
Wisconsin Tornado: Repair Costs Overshadow Lost Sales for US Stocks
Markets

Wisconsin Tornado: Repair Costs Overshadow Lost Sales for US Stocks

The EF-2 tornado in Wisconsin caused localized damage to WEC Energy, Oshkosh, and Illinois Tool Works. Repair costs are expected to be the primary financial impact, exceeding lost sales.

WEC OSK ITW
T-Mobile Restores Network After Outage, Churn Remains Key Risk
Markets

T-Mobile Restores Network After Outage, Churn Remains Key Risk

T-Mobile US (TMUS) has restored service after a major outage, but analysts highlight ongoing churn risks. Shares edged up 0.8% in premarket trading.

TMUS VZ T
Gossamer Bio Surges on FDA Filing Update; Cash Covenant Looms
Markets

Gossamer Bio Surges on FDA Filing Update; Cash Covenant Looms

Gossamer Bio shares surged 46% on FDA feedback supporting its seralutinib NDA filing. Cash covenant and dilution risks persist.

GOSS